Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Radiology, the medical specialty into which AI has made the furthest initial inroads in the U.S., is embracing the technology in France. And this is so despite French radiologists feeling underinformed on AI up to now.
Some are calling the first generation whose members will never have known life without smartphones “Generation Alpha.” And some are predicting they’ll be as reliant on AI as Millennials and Generation Z have been on the internet.
The simultaneous advances of deep learning and radiomics may soon yield a single unified framework for clinical decision support that has the potential to “completely revolutionize the field of precision medicine.”
The FDA has given 510(k) clearance to an AI alert for urgent finding of a collapsed lung in chest X-rays. The approval is a first for an AI-based chest X-ray solution that can help doctors make quicker diagnoses from one of the world’s most used imaging modalities.
AI can predict death or heart attack better than humans, according to a new study presented at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC) in Lisbon.
Combing through insurance claims and other health data on more than 72 million U.S. residents, a machine learning algorithm was able to quite accurately identify more than 222,000 individuals who have very early stage Alzheimer’s disease.
As medical devices are increasingly being touched by new AI innovations, the FDA will soon have to grapple with reality of regulating “living things” in a new way, according to a report from Roll Call.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.